Molecular Dynamics (MD) for Cancer Control Protocol
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Latest Stable Copy and Install It With: Chmod+X Chimera- *.Bin&&./Chimera- *.Bin
Tangram Suite Documentation Release 0.0.8 InsiliChem Mar 26, 2019 General instructions 1 What is Tangram Suite 3 2 How to install Tangram Suite5 3 General usage 7 4 FAQ & Known issues 9 5 List of Tans 11 6 Tangram BondOrder 13 7 Tangram QMSetup 15 8 Tangram DummyAtoms 17 9 Tangram GAUDIView 19 10 Tangram MMSetup 21 11 Tangram NCIPlot 23 12 Tangram NormalModes 25 13 Tangram OrbiTraj 27 14 Tangram PLIP 29 15 Tangram PoPMuSiCGUI 31 16 Tangram PropKaGUI 33 17 Tangram ReVina 35 18 Tangram SubAlign 37 19 Tangram TalaDraw 39 i ii Tangram Suite Documentation, Release 0.0.8 It’s composed of several independent graphical interfaces and commands for UCSF Chimera. General instructions 1 Tangram Suite Documentation, Release 0.0.8 2 General instructions CHAPTER 1 What is Tangram Suite In progress 3 Tangram Suite Documentation, Release 0.0.8 4 Chapter 1. What is Tangram Suite CHAPTER 2 How to install Tangram Suite 2.1 Install the full Tangram Suite (recommended) 1 - If you don’t have UCSF Chimera installed, download the latest stable copy and install it with: chmod+x chimera- *.bin&&./chimera- *.bin 2 - Download the latest installer from the releases page (Linux and MacOS only) and run it with: bash tangram-*.sh 2.2 Using the conda meta-package Instead of using the Bash installer, you can use conda (if you are already using it) to create a new environment with the tangram metapackage, which will handle all the dependencies. While in alpha, both insilichem channels are needed (the main one and also the dev label): conda create-n tangram-c insilichem/label/dev-c insilichem-c omnia-c rdkit-c ,!conda-forge tangram 2.3 Updating extensions Each extension will check if there’s a new release available every time you launch it. -
GROMACS: Fast, Flexible, and Free
GROMACS: Fast, Flexible, and Free DAVID VAN DER SPOEL,1 ERIK LINDAHL,2 BERK HESS,3 GERRIT GROENHOF,4 ALAN E. MARK,4 HERMAN J. C. BERENDSEN4 1Department of Cell and Molecular Biology, Uppsala University, Husargatan 3, Box 596, S-75124 Uppsala, Sweden 2Stockholm Bioinformatics Center, SCFAB, Stockholm University, SE-10691 Stockholm, Sweden 3Max-Planck Institut fu¨r Polymerforschung, Ackermannweg 10, D-55128 Mainz, Germany 4Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 4, NL-9747 AG Groningen, The Netherlands Received 12 February 2005; Accepted 18 March 2005 DOI 10.1002/jcc.20291 Published online in Wiley InterScience (www.interscience.wiley.com). Abstract: This article describes the software suite GROMACS (Groningen MAchine for Chemical Simulation) that was developed at the University of Groningen, The Netherlands, in the early 1990s. The software, written in ANSI C, originates from a parallel hardware project, and is well suited for parallelization on processor clusters. By careful optimization of neighbor searching and of inner loop performance, GROMACS is a very fast program for molecular dynamics simulation. It does not have a force field of its own, but is compatible with GROMOS, OPLS, AMBER, and ENCAD force fields. In addition, it can handle polarizable shell models and flexible constraints. The program is versatile, as force routines can be added by the user, tabulated functions can be specified, and analyses can be easily customized. Nonequilibrium dynamics and free energy determinations are incorporated. Interfaces with popular quantum-chemical packages (MOPAC, GAMES-UK, GAUSSIAN) are provided to perform mixed MM/QM simula- tions. The package includes about 100 utility and analysis programs. -
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
processes Review Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development Outi M. H. Salo-Ahen 1,2,* , Ida Alanko 1,2, Rajendra Bhadane 1,2 , Alexandre M. J. J. Bonvin 3,* , Rodrigo Vargas Honorato 3, Shakhawath Hossain 4 , André H. Juffer 5 , Aleksei Kabedev 4, Maija Lahtela-Kakkonen 6, Anders Støttrup Larsen 7, Eveline Lescrinier 8 , Parthiban Marimuthu 1,2 , Muhammad Usman Mirza 8 , Ghulam Mustafa 9, Ariane Nunes-Alves 10,11,* , Tatu Pantsar 6,12, Atefeh Saadabadi 1,2 , Kalaimathy Singaravelu 13 and Michiel Vanmeert 8 1 Pharmaceutical Sciences Laboratory (Pharmacy), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland; ida.alanko@abo.fi (I.A.); rajendra.bhadane@abo.fi (R.B.); parthiban.marimuthu@abo.fi (P.M.); atefeh.saadabadi@abo.fi (A.S.) 2 Structural Bioinformatics Laboratory (Biochemistry), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland 3 Faculty of Science-Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands; [email protected] 4 Swedish Drug Delivery Forum (SDDF), Department of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden; [email protected] (S.H.); [email protected] (A.K.) 5 Biocenter Oulu & Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7 A, FI-90014 Oulu, Finland; andre.juffer@oulu.fi 6 School of Pharmacy, University of Eastern Finland, FI-70210 Kuopio, Finland; maija.lahtela-kakkonen@uef.fi (M.L.-K.); tatu.pantsar@uef.fi -
Quantitative Evaluation of Dissociation Mechanisms in Phenolphthalein and the Related Compounds
J. Comput. Chem. Jpn., Vol. 15, No. 1, pp. 13–21 (2016) ©2016 Society of Computer Chemistry, Japan Technical Paper Quantitative Evaluation of Dissociation Mechanisms in Phenolphthalein and the Related Compounds Toshihiko HANAI Health Research Foundation, Research Institute for Production Development 4F, 15 Shimogamo-morimoto-cho, Sakyo-ku, Kyoto 606-0805, Japan e-mail: [email protected] (Received: October 11, 2015; Accepted for publication: April 14, 2016; Online publication: May 6, 2016) Computational chemistry programs were evaluated as aids to teaching qualitative analytical chemistry. Compu- tational chemical calculations can predict absorption spectra, thus enabling the modeling of indicator dissociation mechanisms by different computational chemical programs using a personal computer. An updated MNDO program among 51 programs was found to be the best predictor to explain the dissociation mechanisms of isobenzofuranones and sulfonephthaleins. Unknown dissociation constants were predicted from atomic partial charges instead of Ham- mett's constants. Keywords: Quantitative analysis of dissociation mechanisms, Isobenzofuranone, Sulfonephthalein, Computational chemistry 1 Introduction the absorption wavelength and electron density changes were not well described. The dissociation mechanisms, maximum How to quantitatively teach qualitative analytical chemistry is wavelengths, and electron density maps of isobenzofuranones a very important subject for analytical chemists. Previously, a and sulfonephthaleins were, therefore, evaluated by in silico method to teach molecular interaction mechanisms in chroma- analysis despite the anticipated poor precision. The experimen- tography was quantitatively achieved using molecular mechan- tally measured dissociation of phenolphthalein is described ics and MOPAC programs [1]. Furthermore, the reaction mech- using four dissociation structures, where the ionization of two anisms of highly sensitive detections were also quantitatively phenolic hydroxyl groups converts the neutral molecular form described [2,3]. -
UCSF Chimera Was Developed by the Computer Graphics Laboratory at the University of California, San Francisco, Under Support of NIH Grant P41-RR01081
matrixcopy apply the transformation matrix of one model to another tcolor color using texture map colors UCSF Chimera matrixget write the current transformation matrices to a ®le texture de®ne texture maps and associated colors QUICK REFERENCE GUIDE June 2007 matrixset read and apply transformation matrices from a ®le thickness move the clipping planes in opposite directions minimize energy-minimize structures turn rotate about the X, Y, or Z axis mmaker (matchmaker) align models in sequence, then in 3D vdw* display van der Waals (VDW) surface modelcolor set color at the model level vdwde®ne* set VDW radii Commands modeldisplay* set display at the model level vdwdensity set VDW surface dot density *reverse function Äcommand available move translate along the X, Y, or Z axis version show copyright information and Chimera version movie capture image frames and assemble them into a movie viewdock start ViewDock and load docking results 2dlabels create arbitrary text labels and place them in 2D namesel name and save the current selection wait suspend command processing until motion has stopped ac enable accelerators (keyboard shortcuts) neon create a shadowed stick/tube image (not on Windows) window adjust the view to contain the speci®ed atoms addaa add an amino acid to a peptide C-terminus objdisplay* display graphical objects windowsize adjust the dimensions of the graphics window addcharge assign partial charges to atoms open* read structures and data, execute command ®les write save a molecule model as a PDB ®le addh add hydrogens pdbrun -
A Comparative Study of the Efficiency of HCV NS3/4A Protease Drugs
Life Sciences 217 (2019) 176–184 Contents lists available at ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches T ⁎ Ahmed A. Ezat , Wael M. Elshemey Biophysics Department, Faculty of Science, Cairo University, 12613 Giza, Egypt ARTICLE INFO ABSTRACT Keywords: Aims: To investigate the efficacy of Direct Acting Antivirals (DAAs) in the treatment of different Hepatitis C HCV Virus (HCV) genotypes. NS3/4A protease Main methods: Homology modeling is used to predict the 3D structures of different genotypes while molecular Molecular docking docking is employed to predict genotype – drug interactions (Binding Mode) and binding free energy (Docking Homology modeling Score). Key findings: Simeprevir (TMC435) and to a lesser degree MK6325 are the best drugs among the studied drugs. The predicted affinity of drugs against genotype 1a is always better than other genotypes. P2–P4 macrocyclic drugs show better performance against genotypes 2, 3 and 5. Macrocyclic drugs are better than linear drugs. Significance: HCV is one of the major health problems worldwide. Until the discovery of DAAs, HCV treatment faced many failures. DAAs target key functional machines of the virus life cycle and shut it down. NS3/4A protease is an important target and several drugs have been designed to inhibit its functions. There are several NS3/4A protease drugs approved by Food and Drug Administration (FDA). Unfortunately, the virus exhibits resistance against these drugs. This study is significant in elucidating that no one drug is able to treat different genotypes with the same efficiency. -
Parameterizing a Novel Residue
University of Illinois at Urbana-Champaign Luthey-Schulten Group, Department of Chemistry Theoretical and Computational Biophysics Group Computational Biophysics Workshop Parameterizing a Novel Residue Rommie Amaro Brijeet Dhaliwal Zaida Luthey-Schulten Current Editors: Christopher Mayne Po-Chao Wen February 2012 CONTENTS 2 Contents 1 Biological Background and Chemical Mechanism 4 2 HisH System Setup 7 3 Testing out your new residue 9 4 The CHARMM Force Field 12 5 Developing Topology and Parameter Files 13 5.1 An Introduction to a CHARMM Topology File . 13 5.2 An Introduction to a CHARMM Parameter File . 16 5.3 Assigning Initial Values for Unknown Parameters . 18 5.4 A Closer Look at Dihedral Parameters . 18 6 Parameter generation using SPARTAN (Optional) 20 7 Minimization with new parameters 32 CONTENTS 3 Introduction Molecular dynamics (MD) simulations are a powerful scientific tool used to study a wide variety of systems in atomic detail. From a standard protein simulation, to the use of steered molecular dynamics (SMD), to modelling DNA-protein interactions, there are many useful applications. With the advent of massively parallel simulation programs such as NAMD2, the limits of computational anal- ysis are being pushed even further. Inevitably there comes a time in any molecular modelling scientist’s career when the need to simulate an entirely new molecule or ligand arises. The tech- nique of determining new force field parameters to describe these novel system components therefore becomes an invaluable skill. Determining the correct sys- tem parameters to use in conjunction with the chosen force field is only one important aspect of the process. -
3D-Printing Models for Chemistry
3D-Printing Models for Chemistry: A Step-by-Step Open-Source Guide for Hobbyists, Corporate ProfessionAls, and Educators and Student in K-12 and Higher Education Poster Elisabeth Grace Billman-Benveniste+, Jacob Franz++, Loredana Valenzano-Slough+* +Department of Chemistry, Michigan Technological University, ++Department of Mechanical Engineering, Michigan Technological University *Corresponding Author References 1. “LulzBot TAZ 5.” LulzBot, 14 Aug. 2018, www.lulzbot.com/store/printers/lulzbot-taz-5 2. Gaussian 16, Revision B.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Petersson, G. A.; Nakatsuji, H.; Li, X.; Caricato, M.; Marenich, A. V.; Bloino, J.; Janesko, B. G.; Gomperts, R.; Mennucci, B.; Hratchian, H. P.; Ortiz, J. V.; Izmaylov, A. F.; Sonnenberg, J. L.; Williams-Young, D.; Ding, F.; Lipparini, F.; Egidi, F.; Goings, J.; Peng, B.; Petrone, A.; Henderson, T.; Ranasinghe, D.; ZakrzeWski, V. G.; Gao, J.; Rega, N.; Zheng, G.; Liang, W.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; HasegaWa, J.; Ishida, M.; NakaJima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Throssell, K.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M. J.; Heyd, J. J.; Brothers, E. N.; Kudin, K. N.; Staroverov, V. N.; Keith, T. A.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A. P.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Millam, J. M.; Klene, M.; Adamo, C.; Cammi, R.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Farkas, O.; Foresman, J. B.; Fox, D. J. Gaussian, Inc., Wallingford CT, 2016. 3. -
Development and Application of a Computational Platform for Complex Molecular Design Jaime Rodríguez-Guerra Pedregal
ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Development and Application of a Computational Platform for Complex Molecular Design a dissertation submitted by Jaime Rodríguez-Guerra Pedregal & directed by Prof. Dr. Jean-Didier Maréchal in fulfillment of the requirements for the degree of Doctor of Biotechnology Tutor: Prof. Dr. Jordi Joan Cairó Badillo Department of Chemical, Biological and Environmental Engineering Universitat Autònoma de Barcelona July 2018 Development and Application of a Computational Platform for Complex Molecular Design a dissertation submitted by & recommended for acceptance by advisor Jaime Rodríguez-Guerra Pedregal Prof. Dr. Jean-Didier Maréchal Tutor: Prof. Dr. Jordi Joan Cairó Badillo Department of Chemical, Biological and Environmental Engineering Universitat Autònoma de Barcelona July 2018 ©2018 – Jaime Rodríguez-Guerra Pedregal Licensed as Creative Commons BY-NC-ND Attribution-NonCommercial-NoDerivs In the beginning, there was nothing. And God said «Let there be light». And there was light. There was still nothing, but you could see it a lot better. —WoodyAllen. Development and Application of a Computational Platform for Complex Molecular Design by Jaime Rodríguez-Guerra Pedregal Abstract In this dissertation, a series of novel computational modeling tools is reported. -
Hands-On Tutorials of Autodock 4 and Autodock Vina
Hands-on tutorials of AutoDock 4 and AutoDock Vina Pei-Ying Chu (朱珮瑩) Supervisor: Jung-Hsin Lin (林榮信) Research Center for Applied Sciences, Academia Sinica 2018 Frontiers in Computational Drug Design, Academia Sinica, March 16-20, 2018 AutoDock http://autodock.scripps.edu AutoDock is a suite of automated docking tools. It is designed to predict how small molecules, such as substrates or drug candidates, bind to a receptor of known 3D structure. AutoDock 4 is free and is available under the GNU General Public License. 2 AutoDock Vina http://vina.scripps.edu/ Because the scoring functions used by AutoDock 4 and AutoDock Vina are different and inexact, on any given problem, either program may provide a better result. AutoDock Vina is available under the Apache license, allowing commercial and 3 non-commercial use and redistribution. http://autodock.scripps.edu/downloads These programs were installed on VM. 4 http://mgltools.scripps.edu/ AutoDockTools (ADT) is developed to help set up the docking. ADT is included in MGLTools packages. 5 In general, each docking (AutoDock 4 and/or AutoDock Vina) requires: 1. structure of the receptor (protein), in pdbqt format 2. structure of the ligand (small molecule, drug, etc.) in pdbqt format 3. docking and grid parameters (search space) PDBQT format is very similar to PDB format but it includes partial charges ('Q') and AutoDock 4 (AD4) atom types ('T'). • Preparing the ligand involves ensuring that its atoms are assigned the correct AutoDock4 atom types, adding Gasteiger charges if necessary, merging non-polar hydrogens, detecting aromatic carbons if any, and setting up the 'torsion tree'. -
Mai Muuttunut Pilit Muut Aidi Mini
MAIMUUTTUNUT US009963689B2 PILIT MUUT AIDI MINI (12 ) United States Patent ( 10 ) Patent No. : US 9 ,963 , 689 B2 Doudna et al. ( 45) Date of Patent: May 8 , 2018 ( 54 ) CASI CRYSTALS AND METHODS OF USE FOREIGN PATENT DOCUMENTS THEREOF WO WO 2013 / 126794 AL 8 / 2013 ( 71 ) Applicant: The Regents of the University of wo WO 2013 / 142578 A19 / 2013 California , Oakland , CA (US ) WO WO 2013 / 176772 A1 11/ 2013 ( 72 ) Inventors : Jennifer A . Doudna , Oakland , CA OTHER PUBLICATIONS (US ) ; Samuel H . Sternberg , Oakland , McPherson , A . Current Approaches to Macromolecular Crystalli CA (US ) ; Martin Jinek , Oakland , CA zation . European Journal of Biochemistry . 1990 . vol . 189 , pp . (US ) ; Fuguo Jiang , Oakland , CA (US ); 1 - 23 . * Emine Kaya , Oakland , CA (US ) ; Kundrot, C . E . Which Strategy for a Protein Crystallization Project ? Cellular Molecular Life Science . 2004 . vol . 61, pp . 525 - 536 . * David W . Taylor, Jr. , Oakland , CA Benevenuti et al. , Crystallization of Soluble Proteins in Vapor (US ) Diffusion for X - ray Crystallography , Nature Protocols , published on - line Jun . 28 , 2007 , 2 ( 7 ) : 1633 - 1651. * ( 73 ) Assignee : THE REGENTS OF THE Cudney R . Protein Crystallization and Dumb Luck . The Rigaku UNIVERSITY OF CALIFORNIA , Journal. 1999 . vol. 16 , No . 1 , pp . 1 - 7 . * Drenth , “ Principles of Protein X - Ray Crystallography ” , 2nd Edi Oakland , CA (US ) tion , 1999 Springer - Verlag New York Inc ., Chapter 1 , p . 1 - 21. * Moon et al . , “ A synergistic approach to protein crystallization : ( * ) Notice : Subject to any disclaimer , the term of this Combination of a fixed -arm carrier with surface entropy reduction ” , patent is extended or adjusted under 35 Protein Science , 2010 , 19 : 901 -913 . -
Kingston University London the Antibiotic Resistance Growth Plate
Kingston University London The Antibiotic Resistance Growth Plate (ARGP) as an experimental evolution tool to explore the phenotypic and genotypic mutational pathways underlying the emergence of antimicrobial resistance in Escherichia coli. A thesis submitted in partial fulfilment for the degree of Doctor of Philosophy By Lucky Bonnie Lucia CULLEN Faculty of Science, Engineering and Computing February 2019 Declaration This thesis entitled ‘The Antibiotic Resistance Growth Plate (ARGP)’ as an experimental evolution tool to explore the phenotypic and genotypic mutational pathways underlying the emergence of antimicrobial resistance in Escherichia coli’ is based upon the work conducted in the Faculty of Science, Engineering and Computing at Kingston University London and in collaboration with Dr Philip Aldridge at Newcastle University and Katie Hopkins and Neil Woodford from Public Health England. All the work described is the candidate’s own original work unless otherwise stated. None of the work presented has been submitted for another degree internally or externally. i Acknowledgements At the start of this PhD I had a dream, a dream which could have never been accomplished without the support of many people. Firstly, I would like to express my sincere appreciation to my director of studies Professor Mark Fielder, your provision, guidance and unconditional belief in my potential has contributed significantly to the completion of this thesis. I would also like to acknowledge the overwhelming support received from, Dr Scott Lawton, Camilla Eldridge and Ben Jones, your wealth of knowledge and expertise in the field of evolutionary biology and bioinformatics has assisted greatly in concluding the work within this PhD. I would also like to praise the incredible multidisciplinary support received at Kingston University, specifically that from Dr Gary-Forster Wilkins, Dr Adam Le Gresley, Dr Brian Rooney, Dr James Denholm-Price and Richard Giddens.